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ALICE LAM*
 
Despite the burgeoning literature on the network organization as a new mode
of innovation, we know little about how the flow of knowledge across organi-
zational boundaries is intertwined with careers. This study explores the impli-
cations of the network model of R&D organization for the work roles and
careers of R&D scientists within the changing relationship between industry
and the academia. It examines how firms seek to resolve the tension between
science and business by developing closer human resource ties with universities.
It argues that firms have sought to construct “extended” internal labour
markets (EILMs) between themselves and the universities with which they
collaborate, leading to the formation of a hybrid scientific community strad-
dling the two sectors.
 
Introduction
 
A central problem in the management of industrial research & develop-
ment (R&D) lies in the difficulty of resolving the inherent tension between
scientific objectives and industrial goals (Shepard 1956; Kornhauser 1963;
La Porte 1965; Debackere, Clarysse, and Rappa 1996; Randle and Rainnie
1997). Over the past four decades, large industrial firms have developed
different models of R&D organization and career strategies to manage that
tension, and integrate academically trained scientists into the innovation
process. The dominant model of R&D organization has evolved from the
technology-push model of the 1950s and 1960s to the market-pull model of
the 1970s until the late 1980s, and an emerging network model of  today
in which firms use collaborative links and networks of  scientists across
organizational boundaries to support their innovation activities (Rothwell
1992; Liyanage, Greenfield, and Don 1999). These three models reflect the
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changes in the relationship between science and business both within the
firm, and between industrial R&D and the academia (Niosi 1999; Kaufmann
and Todtling 2001). The nature of scientific and technical work, and the
careers of R&D scientists have coevolved with the different models of R&D
organization.
The recent growth of the network model of R&D represents an attempt
by firms to remedy the limitations of the traditional linear technology-push
and market-pull approaches in an environment of rapid change. Instead of
relying on corporate in-house R&D and a cadre of career scientists, firms
have increasingly engaged in various forms of external collaborative
arrangements to gain access to the expertise and open knowledge networks
of  university researchers (Powell, Koput, and Smith-Doerr 1996; Howells
et al. 2003). The increased interchange between industry and university has
been particularly notable in the science-based high-technology sectors where
basic science is increasingly a key source of innovation and economic
advantage (Murray 2002; Meyer-Krahmer and Schmoch 1998; Kaufmann
and Todtling 2001). Several authors have observed a significant shift in the
nature of the relationship between the two sectors from the traditional one-
way flow of  knowledge from universities to industry to closer network ties
characterised by reciprocal flows of people and knowledge (Etzkowitz and
Leydesdorff 2000; Owen-Smith 2003; Powell and Owen-Smith 1998). Ties that
involve the direct engagement of industrial and academic scientists in col-
laborative R&D, and the movement of academic scientists from universities
to firms are becoming more commonplace (Murray 2002; Zucker, Darby,
and Torero 2002; Zucker, Darby, and Armstrong 2002). Thus, the network
approach to R&D is not only transforming the relationship between science
and business, it is also reshaping the occupational roles and careers of R&D
scientists in the knowledge-driven economy.
Despite the burgeoning literature on the rise of the network organization
as new mode of knowledge production and innovation (Powell, Koput, and
Smith-Doerr 1996; David, Foray, and Steinmueller 1999), we know sur-
prisingly little about how the coproduction and flow of knowledge across
organizational boundaries are intertwined with careers and employment
relationships. Accordingly, the aim of this article is to explore the impli-
cations of the network model of R&D for the work roles and careers of R&D
scientists within the changing relationship between industry and the academia.
It argues that many of the traditional tensions and dilemmas in managing
the relationship between science and business manifest themselves in a
much more complex manner under the network model. The study examines
how firms seek to resolve these tensions by developing closer institutional
ties and human resource links with their academic partners. It argues that
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firms have sought to construct “extended” internal labour markets (EILMs)
between themselves and the universities with which they collaborate, lead-
ing to the emergence of a hybrid scientific community straddling industry
and the academia. The empirical evidence is based on five in-depth com-
pany case studies carried out in the science-based high technology sectors
in the United Kingdom.
The article is structured as follows. Section one reviews changes in models
of R&D organization and provides the context for the empirical investi-
gation. Section two describes the research methods and the characteristics of
the case companies. This is followed by an analysis of the case studies in
section three, focusing on the changing nature of  R&D work as the com-
panies have sought to move towards the network model of R&D. The ana-
lysis is based on contrasting the work roles of scientists in two categories of
firms: the market-pull vs. the network model firms. Section four looks at the
new organizational routines and career models that the network firms are
developing to support collaborative knowledge sharing networks between
industry and the academia. Section five discusses the career and institutional
challenges emerging from the closer ties between industry and university.
 
Models of R&D Organization: Implications for the Roles and 
Careers of the R&D Scientist
 
The Technology-push Model: Corporate Centralization of R&D and the
Professional Scientist.
 
The early incorporation of R&D laboratories into
large industrial firms was an attempt to apply linear thinking to the inno-
vation process through in-house accumulation and exploitation of scientific
knowledge. The technology-push model was the dominant approach to
R&D during the 1950s until early 1970s, and it assumed a linear flow of
knowledge from basic research to applied industrial R&D. The university
was the main supplier of fundamental knowledge and qualified scientific
personnel, and the industrial laboratory provided resocialization experience
to integrate academic scientists into an industrial environment (Abrahamson
1964). Within the corporation, R&D was the main driving force behind product
innovation. This period was marked by corporate expansion in R&D invest-
ment, and R&D was centralized and concentrated at the corporate level.
Under this model, the R&D organization resembled that of a professional
bureaucracy characterized by the dominance of the scientific and technical
specialists underpinned by a professional ideology (Child et al. 1983;
Gerpott and Domsch 1985). It stressed occupational specialization and
autonomy of  the R&D experts. There was a clear connection between
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their formal disciplinary expertise and work activities. In other words, the
R&D experts were primarily “Mode-1” (Gibbons et al. 1994) technical
experts whose formal qualification and training defined their work goals and
task boundaries within the corporations.
The scientific autonomy of the R&D personnel, however, gave rise to the
classic conflict between professional and managerial goals and values within
the corporation (Kornhauser 1963; Marcson 1960; Badaway 1988). These
tensions were partially resolved by allowing R&D staff  a high degree of
strategic autonomy while management maintained control over operational
issues (La Porte 1965). Management also sought to elicit the commitment
of R&D staff  by adopting high-trust career strategies through the provision
of long-term job security and careers (Fox 1974; Causer and Jones 1996).
The provision of parallel technical and managerial career tracks was intro-
duced to balance professional and managerial commitments (Allen and
Katz 1986; 1992; Debackere, Clarysse, and Rappa 1996). The technical
ladder attempted to emulate academic working conditions in an industrial
R&D environment.
 
The Market-pull Model: Decentralization of R&D and the Corporate
Scientist.
 
The market-pull model gained currency during the 1980s when
increased product market competition prompted many firms to decentralize
their R&D in order to speed up product innovation, and to pursue more
market-focused R&D strategies through greater use of external subcontractors
(Twiss 1986; Whittingdon 1991).
Within the firm, R&D ceased to be the exclusive responsibility of the
R&D function and became more closely linked to other business activities.
R&D was decentralized to business units, and a market relationship was
established between R&D (as suppliers) and business divisions (as customers),
and project management was used to break the isolation of R&D depart-
ment. Scientific and technical works were reorganized through strategic
planning based on corporate expectations of relevance and accountability.
These changes significantly altered the work roles and career structures of
R&D scientists. The scientist was expected to become more of a corporate
scientist operating at the boundaries between science and business manage-
ment, and increasingly engaged in a variety of techno-commercial roles. The
trend towards downsizing and commercialization of corporate R&D dimin-
ished the traditional technical career path. In its place, there has emerged a
range of what Bailyn (1991) described as “hybrid” career options, for ex-
ample, cross-functional, project-to-project and mixed technical and managerial
roles. These changes have generated a strong sense of role ambiguity and
career insecurity among R&D personnel, and caused perceptions of career
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blockage and under-utilization (Lam 1994; Causer and Jones 1993;
Whittingdon 1991).
A more fundamental dilemma facing firms is the potential difficulty of
attracting and retaining the necessary core scientific personnel. Firms may
choose to delegate and subcontract basic R&D to external research organi-
zations, but the lack of scientific expertise and established research capa-
bility inside the firm could lead to organizational resistance to external
knowledge (Cohen, Wesley, and Levinthal 1990). The long-term weakness
of  the market-pull model of  R&D has become more apparent since the
mid-1990s as the accelerated pace of technological progress makes firms
vulnerable to the destruction of their technological base.
 
The Network Model: External R&D Collaboration and the Role of the Scientist
in Boundary-crossing Knowledge Networks.
 
During the 1990s, many firms
attempted to develop new knowledge-sourcing strategies in order to remedy
the weaknesses of the market-pull approach so as to sustain a long-term vision
and maintain the ability to generate new knowledge. An emerging trend
has been the growth in R&D collaboration with other firms, government
research institutes and universities (Howells 1999; Howells, James, and
Malik 2003).
The recent scientific and technological revolution has also provided a
spur to external R&D collaboration. This has blurred the boundaries
between basic research and applied and development work, and eroded
traditional barriers between scientific and technological disciplines. Radical
product and process innovation in the science-based sectors increasingly
requires a greater variety of  knowledge in different scientific disciplines
and functional areas (Gambardella 1995; Hage and Hollingsworth 2000).
Gibbons et al. (1994) argue that the nature of  knowledge production in
the knowledge-based economy is shifting from “Mode 1” to “Mode 2”, that
is from knowledge production within single disciplines to that within broader,
trans-disciplinary and multiple organizational contexts.
Within the network approach to R&D, firms attempt to enhance their
capacity for knowledge sourcing by developing flexible and permeable
organizational structures to facilitate the creation and flow of knowledge
across organizational boundaries (Reger and Wichert-Nick 1997; Liyanage,
Greenfield, and Don 1999; Niosi 1999). This involves a significant shift in
the relationship between university and industry away from the older linear
model of one-way knowledge transfer to an interactive model of two-way
knowledge exchange between the two sectors. This increased interchange
takes place within a potent and enduring change in public science policy
that seeks to promote closer science and business links (OECD 2000;
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HMSO 1992; DTI 1998). Some authors argue that these developments have
transformed the relationship between university and industry from a once
separate system into a “hybrid regime” (Owen-Smith 2003), with “over-
lapping spheres” and “network interfaces” (Etzkowitz and Leydesdorff 2000)
characterized by reciprocal knowledge flows and mobility of scientists
across the institutional boundaries (Powell and Owen-Smith 1998; Zucker,
Darby, and Armstrong 2002). Others, however, stress the potential for
greater conflict as scientists recruited from these two different communities,
built around fundamentally antithetical sets of norms and cultural orien-
tations, seek to collaborate in joint projects (Dasgupta and David 1994;
David, Mowery, and Steinmueller 1994; David, Foray, and Steinmueller
1999).
The network model of R&D is complex and difficult to manage because
it engages more closely a variety of internal and external actors, spanning
the private and public domains more closely than the two previous models.
The transfer of  knowledge between the open science communities and
private proprietary industrial R&D is inherently difficult, owing to the diver-
gent norms, incentives and modes of communication characterizing the two
communities. Zucker, Darby, and Torero 2002 and Zucker, Darby, and
Armstrong 2002 note that in the transfer of knowledge from academia to
industry, a large part tends to be tacit and uncodified, requiring the bench-
level engagement of firm and academic scientists in cooperative teams, and
the movement of discovering (mainly academic) scientists to firms. The successful
implementation of the network model of R&D will depend greatly on the
development of a new breed of scientists and creation of new career struc-
tures to facilitate collaborative links and knowledge sharing between the
traditionally separate institutional spheres of industry and university.
The empirical study that will be presented examines how the role of the R&D
scientist is being reconstituted within the network form of R&D organi-
zation. It also examines the new career models with which the companies are
experimenting to support boundary-crossing knowledge networks between
industry and university.
 
Research Methods and the Sample
 
The research is based on five in-depth company case studies from two
sectors: three in information and communication technology (ICT) and two
in pharmaceuticals and specialist chemicals. They are all large companies
operating in innovation-intensive industries. All five companies selected for
the study have, or have had in the recent past, well-established in-house
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TABLE 1
T
 
 
 
I
 
 
 
S
 

 
ICT1 Pharma1 ICT2 ICT3 Pharma2
No. of company 
interviews 
Total 
 
=
 
 49
8 interviews at corporate 
labs and operating 
companies 
—Managing director, 
Central Research 
—3 HR managers, R&D 
and business divisions 
—Manager, corporate 
training 
—Manager, graduate 
recruitment 
—2 project leaders, 
Network groups
11 interviews 10 interviews at 
corporate labs
5 interviews at 
Advanced 
Development Labs
15 interviews at corporate 
lab (Discovery)
Corporate level (3): 
—External Relations 
Manager, Group 
Research and 
Technology 
— Manager, Science and 
Policy and Technology 
Strategic Unit 
—Manager, European 
Recruitment 
Business level (8): 
—Fragrance business (4) 
—Catalysis (2) 
—Lubricants (1) 
—Speciality chemicals 
(1)
—Managing director 
—Academic liaisons
manager (twice) 
—4 project leaders/
tech managers 
(4 areas) 
—Principal engineer 
engaged in 
collaborative project 
—Director, hybrid 
research organization
—Manager, 
external research 
group 
—Manager, HR 
—3 project leaders 
(interactors)
—HR Director 
—Learning and 
development manager 
—Recruitment and 
academic liaison manager 
—VP, Medicinal 
Discovery 
—Director, discovery 
biology 
—Director, medicinal 
technologies 
—Head of external 
technology acquisition 
group 
—Licensing and 
collaboration manager 
—Director, project 
management 
—5 project leaders (engaged 
in collaborative projects)
No. of interviews 
with academic 
partners 
Total 
 
=
 
 15
3 interviews at one partner 
university 
—1 professor in networks  
research 
—2 professors in electronic 
engineering
2 interviews at two 
partners universities 
—1 professor in 
organic chemistry 
—1 professor in 
applied catalysis
2 interviews at one 
partner university 
—1 professor in 
computer science 
—1 professor in 
mathematics
5 interviews at three 
partner universities 
—2 professors in 
electronic 
engineering 
—3 professors in 
mathematics
3 interviews at one partner
university 
—2 professors in 
biosciences 
—Head of industrial 
liaison office
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central R&D facilities that conduct long-term or advanced research. They
are, or were, at least until recently, market leaders in their technological
fields and characterized by relatively high R&D intensities. Both sectors,
ICT and pharmaceuticals, are science-based and technology-push inno-
vation has been historically important. The two sectors were chosen to illus-
trate the new innovation challenges facing firms arising from the recent
scientific and technological revolution. This has resulted in technological
convergence and created a new phase of rapid growth in new markets and
products. Firms operating in these industries are on the one hand under
intense pressure to speed up innovation through the adoption of market-
induced innovation strategies, and on the other, to maintain their core
technological base and develop capabilities in the newly emerging multi-
disciplinary scientific fields. The companies selected for the study differ in
their ability to balance the opposing forces. Two of the companies (ICT1
and Pharma1) have remained driven by market-pull forces, whereas the
other three (ICT2, ICT3 and Pharma2) have sought to move towards the
network model by developing knowledge sourcing strategies and closer
network ties with universities (see succeeding discussion).
Data were collected by semi-structured interviews with technical manag-
ers and scientists in R&D laboratories, managers in human resource groups
and technical staff  directly engaged in external technology acquisition and
collaborative projects with academic institutions. The first points of contact
for interviews were the technical director and academic liaison or external
technology manager at the corporate laboratories. The aim was to collect
background information on the companies’ innovation strategies and R&D
organization, and recent developments in their external knowledge-sourcing
strategies. This provided the necessary contextual information for sub-
sequent interviews with staff in other functions. In the two companies (ICT1
and Pharma1; see Table 1) where the central laboratories have been drama-
tically run down and most of the R&D activities were carried out at the
business division level, the interview samples included a mixture of staff  at
the corporate and divisional levels. In the other three cases (ICT2, ICT3 and
Pharma3) where the corporate laboratories remain important, the majority
of the interviews were carried out at that level. The semi-open question-
naires covered four main areas: organization of  R&D and innovation
strategies, skills and knowledge sourcing, human resource strategies and
recruitment, and links with universities. Interviews were also carried out
with the university academics engaged in collaborative projects with the
companies. A total of  49 individual interviews were carried out in the
companies, and 15 interviews with their academic partners. Each interview
lasted for about an average of  75 minutes and all were recorded and
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TABLE 2
A
 
 
 
P
 
   
 
R&D
 
 
 
O
 
   
 
F
 
 
 
C
 

 
The company
ICT1 (Industrial 
and communication 
electronics)
Pharma1 
(Specialist 
chemical)
ICT2 (Computing 
and communication)
ICT3 (Telecom-
munications equipment 
and network services) Pharma2 (Pharmaceutical)
Model of  R&D 
organization
“Market-pull” “Market-pull” “Network” “Network” “Network”
R&D 
organization
Historical reliance 
on protected defense 
market. But this has 
contracted over the 
past decade. Shift 
towards industrial 
electronics exerted 
strong pressures to 
introduce market-
orientation in R&D 
programs.
The R&D 
function has 
become totally 
decentralized and 
distributed to the 
business units. 
There is a core 
R&D group at the 
corporate level 
but it is now very 
small (about 
45 people), 
performing 
primarily a 
networking and 
coordinating role.
R&D distributed 
between corporate 
and divisional labs. 
Corporate labs 
globally distributed; 
employing 800 people 
in six sites around the 
world. UK site of  
corporate labs; 
employing around 200 
staff.
The company had 
developed a strong 
technology-oriented 
culture with a centralized 
R&D organization. In 
1998, this was dissolved 
and R&D function was 
distributed amongst the 
business lines, with an 
Advanced Technology 
Group remaining at the 
corporate level. European 
R&D headquarters in 
UK serve as advanced 
development centres, 
employing around 1500 
staff.
The company boasts the industry’s 
largest pharmaceutical R&D 
organization: its global R&D 
division, with approximately 
12,000 employees, six discovery 
sites. Central research organized 
as a globally distributed network. 
The Discovery Group at UK site 
(European headquarters) employs 
640 staff. 
Recent 
development
Recent history has 
been marked by de-
merger of less 
successful business 
segments. Both 
number of  
employees and 
amount of  R&D 
Until the early 
1990s, the 
company was a 
large, vertically 
integrated 
chemical-
pharmaceutical 
conglomerate,
Reorganization of 
company into four 
autonomous business 
divisions. Central labs 
also organized into 
four research 
programs seeking 
closer business 
There is no longer a 
central R&D budget. 
R&D regarded as one of  
the activities, amongst 
others, developed by the 
businesses. As a result, 
the company’s 
technology base has 
Rapid expansion and growth; 
increased global coordination in 
R&D. The company has formed 
alliances with more than 250 
partners in academia and industry 
that strengthens its position in 
science and biotechnology.
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have diminished 
significantly. Sold 
off  to foreign 
electronics group in 
2000. 
with a strong in-
house R&D. This 
model was 
abandoned in 1992 
as the company 
transformed itself  
into a specialized 
chemical company. 
From mid-1990s, 
the company 
reorganized itself  
into autonomous 
business units, 
and decentralized 
its R&D to the 
business units.
alignment. Increased 
business influence 
over research agenda.
become much narrower 
than it was ten years ago.
Role of corporate 
labs
Primarily an internal 
contracting agent 
for operating 
companies, and 
more recently, 
external contract 
research.
Diminished and 
almost non-
existent. 
Corporate R&D 
is essentially a 
distributed 
network across 
the different 
businesses, with a 
central core of 
technology 
leaders acting as 
champions for 
key scientific 
areas important 
to the company as 
a whole. 
Remain strategically 
important in 
searching for radical 
breakthrough 
technologies.
Advanced technology 
group and development 
centres play strategically 
important role in internal 
and external knowledge 
networking.
Increasingly work in collaboration 
with external research 
organizations and biotechnology 
companies.
The company
ICT1 (Industrial 
and communication 
electronics)
Pharma1 
(Specialist 
chemical)
ICT2 (Computing 
and communication)
ICT3 (Telecom-
munications equipment 
and network services) Pharma2 (Pharmaceutical)
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Special 
organization to 
sustain 
fundamental 
search cability
None Internal networks 
of senior 
scientists/
technical 
managers to 
identify 
strategically 
important 
scientific areas.
“Basic research 
initiatives” at 
corporate level to 
protect basic research.
External research group 
coordinates worldwide 
university links. It has a 
strategic role in searching 
for disruptive 
technologies.
External technology acquisition 
unit. Significant increase in 
external technology investments 
over the last few years.
University links Diminished 
resources for 
establishing close 
links with 
universities. 
University links 
have become more 
focused on specific 
priority 
technological fields 
central to current 
businesses.
Diminished 
resources for 
university links. 
Build fewer 
relationships with 
universities, 
focusing on 
specific areas of 
direct relevance to 
businesses.
Strategic university 
relations program 
Hybrid research 
organizations.
Global university 
relationships program 
Hybrid research 
organizations.
Postdoctoral collaboration; 
Strategic research collaboration. 
Strategic recruitment specialists to 
develop strategic relationships 
with universities.
The company
ICT1 (Industrial 
and communication 
electronics)
Pharma1 
(Specialist 
chemical)
ICT2 (Computing 
and communication)
ICT3 (Telecom-
munications equipment 
and network services) Pharma2 (Pharmaceutical)
 
TABLE 2 (cont.)
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transcribed. The interviews were conducted between 1999 and 2001. The
interview sample is shown in Table 1.
 
A Profile of the Case Study Companies
 
Table 2 gives a summary of the profiles of the R&D organizations of the
five companies. Two of the companies, ICT1 and Pharma1, are referred to
as “market-pull” firms, while the other three (ICT2, ICT3 and Pharma2)
can be classified as “network” firms.
All the companies looked at in the study introduced major structural
changes in their R&D organizations and innovation strategies from the
latter half  of the 1990s. One dominant trend has been towards greater
decentralization of R&D, and a closer alignment of R&D programs with
business objectives. In most of the companies (with the exception of
Pharma2), the corporate R&D function has become smaller than before,
and in one case (Pharma1), it performs primarily a coordinating function
within the distributed R&D units across different businesses. The greater
decentralization of R&D has led to increased business influence over the
R&D agenda and narrowed the knowledge bases of the companies. One can
argue that the market-pull model of R&D has become deeply entrenched in
all the five companies as sources of R&D funding shifted from corporate to
business units, and corporate R&D became more directly engaged in product
development addressing the needs of specific business units.
However, the companies differ in the extent to which they use external
knowledge networks to counter-balance the drift towards market-driven,
short-term R&D. The R&D model pursued by ICT1 and Pharma1 remains
heavily business-driven. Both companies have drastically downsized their
corporate laboratories and decentralized R&D to the autonomous business
units. Although ICT1 maintains its corporate research laboratory, it is now
primarily an internal contracting R&D agent for the operating companies,
and is also increasingly engaged in external contract research to generate
income. During the 1990s, ICT1 spun off  a number of less successful busi-
ness segments. Both the number of R&D employees and amount of R&D
undertaken diminished significantly. While the company recognizes that
external research links are important for sustaining its technological base,
its resources for maintaining such links appear to be limited. The situation
in Pharma1 is rather similar. From the mid-1990s, the company embarked
on a program of decentralizing its R&D functions to the business units.
This accelerated in the late 1990s as the company underwent a major portfolio
shift from commodity to specialty chemicals. The corporate R&D function
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in Pharma1 has now almost disappeared. It comprises merely a core group
of around 45 research managers operating as a central coordinating unit for
the strategic management of the company’s technology base—down from
1500 R&D staff  in the early 1990s.
Historically, Pharma1 has funded research and educational programs in
universities for the recruitment of graduates and post-docs. This has now
changed. Over the last few years, the company has sought to build fewer
relationships with universities and focus on specific research areas of direct
relevance to the business. The recruitment of  R&D specialists appears to
be less pressing as the company now looks for more generalists to fill the
growing number of techno-commercial roles in the business units. As noted
by the Academic Relations Manager interviewed, “. . . the out and out
scientists—we won’t be recruiting as many. And we will be recruiting
more generalists. And what you will find is that because of that, in due
course, we’ll not be recruiting as many PhDs because we won’t need the
specialization”.
In contrast, in the three network model companies (ICT2, ICT3 and
Pharma2), the role of corporate R&D remains strategically important.
There have been serious attempts at the corporate level to counter-balance
the pull towards short-term, market-driven R&D objectives by maintaining
their core scientific base and technological capability. This is achieved by
the recruitment of core groups of PhD scientists and also by gaining access
to the external academic knowledge base through developing long-term
strategic relationships with universities. ICT2 introduced a “Basic Research
Initiative” in 1994 to set up basic research programs with major research
universities in the United Kingdom and United States. In 1995, it developed
a “Strategic University Relations Programme” on a global scale. Its mission
was to develop long-term partnerships with a small number of  key univer-
sities. These academic links constitute the foci of the companies’ external
knowledge networks and provide important channels for recruiting and
gaining access to top academic researchers. Likewise, ICT3 has been placing
an increased emphasis on establishing collaborative links with universities
amidst the drift towards more market-driven R&D. Links with the aca-
demic knowledge base are now seen as critical for generating new ideas and
sustaining the company’s long-term innovative capability. To put this in the
words of the company’s external research manager: “. . . the chances of us
inventing something outside our core business have gone. And in some ways
that’s what we are looking at universities for.” ICT3 has recently introduced
a global university relationship program, managed by an External Research
Group which reports to the Vice-President of Disruptive Technologies at
the corporate level. The group has a strategic role in searching for new
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directions of research and ensuring that the relationships with the academia
generate disruptive ideas that will shape the company’s future businesses.
The company also stresses the importance of using a bottom-up process for
initiating collaborative links with external partners. The R&D scientists and
engineers are expected to maintain their own academic networks to facili-
tate the search for external partners and opportunities for collaboration. In
the case of Pharma2, links with academia have always been important but
the recent growth in the scientific intensity and complexity of drug research
has further strengthened the propensity of  the company to enter into
collaborative relationships with external research organizations and univer-
sities. Pharma2 increasingly recognizes that it “doesn’t have a monopoly of
good ideas” and that “outside collaboration fosters innovation”, according
to the head of external technology group. There has been a significant
increase in the company’s external technology investments in recent years.
The worldwide budget for external research collaboration more than
tripled between 1995 and 2000. Moreover, the recruitment of PhD scientists
is seen as critical for maintaining the company’s academic networks. In the
face of growing competition for qualified scientific personnel, Pharma2 has
sought to develop a more focused and targeted approach to the ways it
relates to higher education institutions. The Director of Human Resources
in Central Discovery described recruitment as a very “tough” area. Forging
closer academic links has become so important that the company has
recently created “strategic recruitment specialists” to liaise and develop
strategic relationships with, what he called, their “preferred institutions”.
This contrasts with the retrenchment in the two market-pull companies
characterized by a reduction in corporate R&D and increased focus of the
remainder on immediate product market needs.
The next section explores the impact of the network model of R&D on
the work roles and careers of scientists, using the contrast between the
previously discussed two categories of companies.
 
Nature of R&D Work in Network Firms
 
Conflict in Goals between Science and Business.
 
Evidence from the inter-
views shows that the tension between science and business has been largely
reconciled in the market-pull firms through the recruitment of a new breed
of corporate scientists and the creation of a variety of techno-commercial
roles. The classical image of the professional scientist engaged in auto-
nomous research is virtually nonexistent in these companies. Hence, balancing
opposing demands for individual scientific autonomy with business goals
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has ceased to be a key tension for the majority of the technical staff  in these
firms.
In contrast, their counterparts in the network firms are exposed to multi-
faceted conflicting demands, and there appears to be considerable anxiety
about managing the difficult interface between the scientific and business
worlds. This reflects the tension inherent in the innovation strategies
adopted by the network firms which seek, on the one hand, close inte-
gration and alignment between R&D and businesses, and on the other,
maintenance of their scientific and technological base. The scientists in the
network firms are expected to be both corporate and professional scientists,
having to deal with some of the same business demands as those in the
market-pull firms, but also to maintain their place in scientific networks
outside the firm. I shall deal with these two aspects in turn.
First, like the corporate scientists in the market-pull firms, they have to
engage closely in the business and commercial activities of the corporation:
 
“. . . we have to go out and start negotiating building business contracts, busi-
ness leads with partner companies which are very different to how it used to
be. It used to be, we develop technologies, we then go to our divisions, out on
the company, if  they would got sold on the idea they would put their R&D
facilities on it to take it into manufacture, into product . . . we don’t do that so
much anymore . . .” (R&D scientist, ICT2).
 
An increasingly important part of their role is to transfer technology and
“deliver value” to the company:
 
“Transfer is rated extremely high in performance, so if  anything, the measures
would encourage people not to worry about research but to worry about
being relevant to the company . . . I think if  we go too far down that business
road, we won’t have ICT2 labs. It will cease to exist. Because it won’t be, no
fundamental research will come out of  it” (R&D scientist/group leader,
ICT2).
“When I arrived here there was much more of a culture of, there were many
different ways in which we can deliver value, we could do fundamental
research, we could have visibility in the outside world, we could deliver value
to divisions etc. You know you could publish papers . . . and so on. And actually
after of a couple of years of that we worked very hard to start to engender the
culture that what mattered was that you were delivering value to the company”
(R&D scientist, ICT2).
 
A result of the closer business alignment and emphasis on technology
transfer is that many of the scientists saw their discretion and control over
selection of R&D projects eroded:
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“So historically what we always invested in was always our decision. The way
that this process is operated this time the individual businesses are being asked
to bear the cost of the research that ICT2 labs is doing for that business, and
some of them will say, ‘no I can’t afford that’ . . . And so suddenly our freedom
to take decisions and invest in what we thought, you know, was right will be
severely curtailed” (R&D scientist, ICT2).
“In the past, we had a lot of discretion. This last reorganization––which is just
part of life swings and roundabouts––has taken us very closely into being
managed by the divisions, by the major business as to what we invest in. We’re
not quite as free as we were to invest where we like” (R&D scientist/group
leader, ICT2).
 
Others find it difficult to fit their good ideas into the line of business, or
maintain their expertise as R&D projects become embroiled in the ups and
downs of business contracts:
 
“At the moment it’s very much ‘line of business focus’ and I particularly
noticed that when I recently came up with a patent idea, an idea to patent, and
the problem with it be not being centralized meant that even though it was a
good idea it didn’t have an obvious home. You know it wasn’t one of these lines
of business and therefore to try and get somebody to pay to have it patented,
it was not obvious. . . . But the thing that makes it important is that’s it’s a
novel idea and that it’s going to be worth money. But the problem is fitting it
into that structure” (project leader, ICT3).
“I think people in my group feel more vulnerable . . . They have to deal with
the fact that they had to give up on work they have invested in for the last two
to three years, customers they have built relationships with, and start from the
ground zero, to find what are we gonna do in this new space. Nobody knows
what we should be doing, we have to invent it ourselves, what we are gonna do
with it, talk with customers . . . There is quite a lot of reinventing and re-
structuring . . .” (R&D scienitst/group leader, ICT2).
 
Even in Pharma2 which maintains a strong corporate laboratory, some of
the scientists expressed concerns about the difficulties in maintaining their
scientific expertise:
 
“. . . we work on very focused research. Everything we do is towards drug
discovery. If  there ain’t drug coming out of it, we don’t do it. So we might
find interesting things that might be interesting academically that we never
pursue . . . So one day I might work on a kinase. Tomorrow that might go
down and then I might work on a proteose or I might work on a receptor. And
I would only work on it if  it were allergy and respiratory-based . . . When I
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started at Pharma2 I was kind of like in between academics and I sort of, I
was going to do the same sort of thing only in a different environment. But
now, I do completely different things from academics . . . I couldn’t go back to
university and do academic science because it’s too different . . .” (Research
scientist, Pharma2).
 
Turning to the second aspect of the role tensions of scientists in network
firms, amidst the drift towards business-driven R&D and the erosion of
scientific autonomy, R&D staffs are expected to maintain their professional
scientific capability so as to sustain a research culture in the laboratories.
Many of the R&D managers interviewed talked about the importance of
patenting, publications, and maintaining their “visibility in the wider
research community.” The following remarks made by a departmental
manager in ICT2 is illustrative:
 
“I kind of hope that the experienced staff  they’re actually all in the right forum
where things are happening, so they just know every one who is important in
the area . . . It’s to be part of the wider research community in this place, and we
certainly expect that from our staff. So this is attending the right conferences,
the right trade shows, you know the standard bodies that are influential, the
universities. . . .”
“I still encourage publications and patenting and all those things . . . To sustain
a group you have to be part of the wider research community, in fact to help
our products you have to be part of that wider community and be taken
seriously, and you can’t do that if  you don’t publish and you don’t give papers
at conferences. You don’t have to do huge amounts but you’ve got to be
there . . . So it’s a difficult tension to manage . . .”
 
Although it is not entirely clear whether these constitute formal perfor-
mance criteria, several of the managers interviewed stressed the need to
maintain ambiguity to avoid what they called “errant behaviour.”
In contrast with the market-pull firms which no longer regard the recruit-
ment of PhD specialists as core to their human resource strategy, the net-
work firms continue to stress the critical role of PhD scientists in sustaining
their core scientific base and external research networks. For example, for
Pharma2, the recruitment of high quality PhD scientists has become so
important that the company has recently created “strategic recruitment
specialists” staffed by senior PhD scientists to help identify the candidates,
using their academic scientific networks, and to show “the best face to the
external world,” as pointed out by the human resource director. In ICT2
and ICT3, although both companies recognize that they are looking for
more scientists with practical business experience, the recruitment of what
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one manager describes as “out now, pure researchers” with PhD qualifica-
tions remains essential.
 
Multidisciplinary Project Teams: The “Specialization-Flexibility” Dilemma.
 
The general trend observed in all the companies has been increasingly to
organize R&D work on a cross-functional and multidisciplinary basis. The
classic tension between specialist and project groups has long been dis-
cussed in the literature (Shepard 1956; Cordero 1999). While the former
facilitates the development of deep expertise and solidarity among members
of a discipline, the latter enables the organization to attain greater flexibility
in the utilization of expertise in shifting problem contexts.
In the market-pull firms, project groups are used primarily as vehicles for
facilitating a greater degree of science and business interaction in order to
speed up product development. Thus, a central management focus has been
on the development of cross-functional teams aiming at closely integrating
R&D into the product development and business cycles. In the network
firms, project teams serve the additional purpose of  developing cross-
disciplinary scientific capability for solving complex problems. The increased
multidisciplinary nature of R&D work has meant that the scope for the
R&D staff  to maintain and develop their core scientific expertise has been
reduced. While this may not necessarily be perceived as a problem in the
market-pull firms, for the scientists in the network firms where technical
excellence and scientific reputation are still regarded as important for career
advancement, the difficulty in maintaining their core expertise is causing
anxieties.
For example, some of the R&D staffs interviewed are concerned about
losing their expertise as they move around different projects. A senior
researcher at ICT2, who joined the company from academia several years
ago, expressed his anxiety:
 
“So one of the main things about working for ICT2 is exactly that. That you
have an area of expertise, but then you also have to . . . its product has lots
more things in it that are not my area of expertise. Recently, I’ve had to learn
about optics because they were relevant to particular product concepts we were
playing with . . . I suppose I had to find out something about sensor techno-
logy which, again, is totally outside my area of expertise. So yes, it’s very much
multidisciplinary. So we have partially multidisciplinary teams. And we have to
get off  our own areas of expertise. I think a lot of people find that that dilutes
their area of expertise”
“One of the things that worried me about coming here was losing my skills. As
projects move about. But once you’ve made a position, and got yourself  ‘This
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is what I do’, as long as the winds of change aren’t so great then you can keep
on doing it. But eventually, you can’t resist the changes that can happen in an
organization like this” (R&D scientist, ICT2).
 
Others talked about problems of isolation in mixed project teams:
 
“You know, they have to learn a bit about other disciplines, they have to inform
people about what they are bringing to the party. The drawback is that if  you
just got one physicist he feels a bit lonely that he hasn’t got a natural group.
So what you find in ICT2 labs is that the electrical engineers they tend to
group together a little bit, socially and sort of in the background. They help
each other out and they form their own sort of community, or guild in a
sense . . . We have here only a few physicists and sometimes they feel a bit
lonely” (project leader, ICT2).
 
The tension between disciplinary-based specialist groups and project
teams is especially notable in Pharma2, a company which seeks to maintain
a deep scientific base and yet the growing complexity of drug discovery
increasingly requires inputs from a diverse range of disciplines and cross-
disciplinary team working. The company has recently moved away from the
traditional disciplinary-based structure (such as biochemistry versus cell bio-
logy) and reorganizes project teams around therapeutic areas (such as tissue
repair, and allergy and respiratory) that draw on the inputs of different
disciplinary groups. As a result, the scientists from disciplinary groups move
around different therapeutic areas. This new structure was resisted by some
of the scientific teams who sought to revert back to the skills-based structure:
 
“But we are now thinking of reorganizing around skills base. Because we just
feel that within a team environment it’s better when you’re talking science, for
instance, you can have a collection of people who are able to critique that
science” (group leader, Pharma2).
 
A compromise solution adopted by the group was to integrate the
disciplinary-based teams into a therapeutic area in order to maintain a
degree of scientific stability:
 
“What we decided was that it would be better for us to merge with their
therapeutic area because then we could learn that therapeutic area more
intensely and become part of the idea generation etc; whereas before we could
get moved around therapeutic areas as needs be so you couldn’t become
experts in anyone . . . The idea of that was just that it gave us some stability in
terms of the science we were exposed to. But in theory if a particular therapeutic
area needed a lot of help and others didn’t, then you could get moved around”
(group leader, Pharma2).
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However, Pharma2 is seeking to move further down the path of multi-
disciplinary team working. A senior executive interviewed stressed the need
to develop more “multiskilled” scientists to work in teams. The existence of
a strong disciplinary culture is increasingly regarded as problematic by the
management:
 
“. . . Physicists tend to think physics. Chemists tend to think chemistry,
Biology and so on. We have to do something to bring these people together . . .”
(human resource director, discovery laboratory, Pharma2).
 
The experience of Pharma2 illustrates the “specialization-flexibility”
dilemma encountered by the research-based firms, and the growing diffi-
culty for industrial scientists to maintain their specialist expertise within
fluid project-based organizations.
 
Networking: The Scientist in Boundary-crossing Knowledge Networks.
 
As firms move away from centralized R&D and increasingly depend on
distributed knowledge sources, a growing part of the scientist’s role is to
engage in a diverse range of internal and external knowledge networking
activities. Although external knowledge sourcing is important for all the
firms looked at in the study, the nature of knowledge networks and role of
scientists differ markedly between the market-pull and network firms.
Simplifying somewhat, one could characterize the market-pull model of
knowledge sourcing as running from the customer through the manager to
the scientist. Thus, it is the manager, rather than the scientist, who plays the
key role in coordinating and monitoring collaborative projects to ensure that
they are tightly focused on the strategic objectives of the businesses. For
example, Pharma1 created a central technology board around the mid-1990s
as it downsized and eventually dismantled the corporate laboratory in the
late 1990s. The central technology board consists of the R&D directors from
the different business units and is responsible for identifying and integrating
the knowledge and skills needed to meet the company’s strategic business
objectives. Collectively, the R&D directors are responsible for managing the
company’s external projects to ensure that they generate the necessary knowl-
edge and competence for the chosen fields of business. A result of this
business-oriented, top-down approach to knowledge sourcing is that there
is relatively little scope for the individual scientists to mobilize and develop
their scientific networks independently of the firm’s formal collaborative
projects and structures. In other words, the scientists in the market-pull firms
are not the main players in developing the firms’ external knowledge networks.
In contrast, their counterparts in the network firms are the key actors in
connecting the internal knowledge base of firms with external knowledge
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networks. The role of the scientist in the network firms increasingly re-
sembles that of a “strategic broker” (Reich 1992) or “boundary-rider” (Turpin
and Deville 1995) whose key task is to network and manage knowledge
boundaries across different contexts, both internally within the firm, and
externally with scientific colleagues outside.
Internally, the R&D scientists have to manage the boundary relationship
between the laboratories and other areas of the business in order to exert
their influence over the R&D agenda. Once able to control outcomes of their
work through direct control of resources, scientists must now use personal
influence and networking to achieve similar ends. For example, the researchers
in ICT2 saw networking with a variety of people outside the central labo-
ratory as a means of “selling” their ideas and getting things done:
 
“. . . the leader of the business unit here would shape things even more . . . And
so we would have good links with the R&D folks, we’d need to work with the
R&D manager, the section manager, and technical folks would need to get into
good liaison with the leading technical opinion formers in the division, you
know and we’d talk to the general manager. And so then if  we wanted to sell
them a strategy or an idea you could do that” (R&D scientist, ICT2).
“[This] is a company of networking, of personal networks . . . you are exposed
to the whole width of the company . . . I think it’s astonishing me joining the
company from where I’ve come from, in this position I had not only the ability
but the expectation to go and talk to very senior people in the company . . .
You have to network to work . . .” (R&D scientist, ICT2).
 
Externally, the scientists are encouraged to develop formal and informal
personal networks and scientific links to the support firms’ external knowl-
edge sourcing and collaborative activities. The manager responsible for
coordinating external research at ICT3 pointed out that the majority of the
company’s collaborative projects were initiated bottom-up from the external
personal contacts of their scientists who act as “interactors” on the projects:
 
“. . . the majority of projects I think will come bottom-up because interactors
[scientists] want the work done, and particularly in a lab like this, which is an
advanced technology lab—I don’t know how many PhDs we’ve got here . . .
but what I was saying is that because there are so many people who have a
research background, and they go to conferences and they keep up-to-date
with what’s happening, they have their contacts into the university anyway. In
most areas, they don’t need me to find them for them” (manager, external
research, ICT3).
 
The importance of mobilizing the professional networks of scientists is
also stressed by a manager in Pharma2:
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“Much of the seeking for collaborative opportunities is done by the scientists.
So they’re going out looking for collaborative opportunities and they spoke
about that . . . going out and bumping into academics at meetings and so
on . . . ” (manager, external technology acquisition, Pharma2).
 
Although large collaborative projects are monitored closely by senior
managers, the “broad involvement of scientists” is regarded as critical for
the success of such projects in the network firms. Pharma2, for example,
places a strong emphasis on “getting the science right” in their collabo-
ration through the close engagement of bench-level scientists. The develop-
ment of informal personalized networks between the scientists and their
external colleagues within formal collaborative projects are encouraged to
ensure that new knowledge generated can be rapidly fed into problem-
solving teams within the firm. A technical director responsible for coordinating
a major academic collaboration commented on the importance of building
scientific links to ensure project success:
 
“. . . Good links between the scientists. This is a scientific collaboration and so
it has to be driven by the science, and I’ve moved too far away from the lab
now to be making quality technical thinking. Science moves too quickly. You
have to involve the scientist on both sides . . .”
 
For the individual scientists, building close links with external academic
colleagues not only constitutes an essential part of their work, it could also be
an important avenue for claiming expertise and making career advancement.
Especially in turbulent and fast developing technological fields where expertise
depends not so much on an accumulated stock of knowledge but more on one’s
ability to gain rapid access to evolving new knowledge, the development of
extensive external knowledge networks becomes critical. For example, a young
project leader in ICT3 was able to make rapid advance in his career because
he had established himself  as the “centre of expertise” in an important new
technological field through his extensive academic links and close involvement
in several collaborative projects. He took pride in pursuing a new “middle”
career path situating between the traditional managerial and technical routes:
 
“. . . people find it hard to become international experts. I’ve personally man-
aged it but I still associate myself  with the middle path . . . In my case, because
we have a technology that I’ve introduced to the company and built up a team
and got involved in many projects . . . Yes, we’ve got lots of external links”
(project leader, ICT3).
 
His academic collaborator also commented on how the university contacts
helped the project leader established his position as a “specialist” in the company:
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“. . . So many of these areas were new to him and then the university contacts,
as far as he is concerned, get him up and running as quickly as possible. And
internally he is very much in demand because he is known to be the person
who is a specialist in this area” (academic collaborator, ICT3).
 
In sum, scientists in the network firms increasingly operate within the
boundary-crossing knowledge networks between industry and the academia.
Within the firm, they are “research gatekeepers” (Tushman 1977: 592) who
connect firms’ R&D projects to state-of-the art knowledge inputs from the
outside research communities. Externally, they operate as what Turpin,
Garret-Jones, and Rankin (1996) describe as “boundary riders” to protect
the firms’ proprietary knowledge resources and investment in collaborative
projects, while at the same time, engaging in open knowledge exchange
with their external colleagues in order to explore and identify new scientific
advances. Here, the requirement of industrial secrecy inevitably comes into
conflict with the norm of open communication. “Knowing what they can
say and what they can’t say,” according to a Pharma2 manager interviewed,
is “often one of  the things that scientists have to struggle with.” Such
conflict in communication norms, however, manifests not only in tension
between the scientist and the firm as discussed in much of the literature, but
also between the industrial researchers and academic scientists. Differences
in research timescale, work norms, and ownership of research results appear
to be the key areas of contention. Although industrial and academic scien-
tists are both involved in the research community, their additional partici-
pation in different organizational systems governed by divergent goals and
careers systems could be a barrier to open knowledge exchange.
 
Building Industry–University Collaborative Knowledge Networks
 
Network Model of R&D and Problems for Firms in Skills and Knowledge
Sourcing
 
. The evidence presented previously shows that many of the old
tensions and dilemmas in managing the relationship between science and
business manifest themselves in a much more complex manner within the
network model of R&D, spanning industry and the academia. A fundamen-
tal challenge for firms is to manage the emerging network interface between
the two sectors. The problems that firms will have to deal with are two-fold.
The first is the recruitment of a core group of scientists, especially at the PhD
level, who will be able to connect the firms’ internal R&D with the external
academic community. However, evidence from the interviews suggests that
firms are finding it difficult to attract and retain the best scientists—many
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of whom appear to be reluctant to pursue a career in an industrial environment
where there is little scope for conducting long-term research and building
specialist expertise within a stable scientific environment. As noted by the
human resource director of Pharma2: “increased external knowledge sourcing
could take away interesting work from scientists.” A research director at ICT3
also pointed out that the company was having difficulties in attracting the best
scientific researchers because “ICT3 Laboratories wasn’t seen to be thinking
sufficiently long-term for them to feel that their talents could be realised in
that space.” Thus, a key challenge for the network firms is to devise new
strategies to tackle what Liebeskind et al. (1996) describe as the “intellectual
resource immobility” problem. New organizational arrangements are
needed to gain access to the best scientific researchers based at universities.
A second problem arises from the difficulties in transferring knowledge
across organizational and institutional boundaries. Knowledge is by nature
sticky and has a tacit dimension, its transfer requires social interaction and
mobility of people (Polanyi 1962; Lam 2000). The direct transfer of knowl-
edge between industry and the academia is especially difficult because of the
divergent goals and career objectives sought by members recruited from the
two different communities (David, Foray, and Steinmueller 1999). Firms
will need to develop new coordination mechanisms and career structures to
support the development of cooperative scientific team to ensure that new
knowledge generated through common projects can be effectively trans-
ferred and integrated into their innovative competences.
Evidence based on the case analysis suggests that the network firms are devis-
ing new structural mechanisms to foster closer ties with their academic partners.
The new policy strategy comprises three key components: (1) developing “strategic
partnerships” with key universities; (2) creating hybrid organizations located
at the interface between firms and universities; and (3) the employment of “linked
scientists” at networks nodes to bridge the interface between the two sectors.
 
Building Strategic University Partnerships for Human Resource and Knowledge
Flows.
 
A significant development observed in the three network firms is the
tendency to develop closer ties with a smaller number of key universities.
The main objective of the firm is to focus attention and concentrate
resources on a small number of key institutions from which they are most
likely to acquire their people and knowledge. The term “strategic partner-
ship” is often used to denote an intention to forge long-term, multidimen-
sional ties and trusting relationships with their “preferred institutions.” The
relationships are usually sustained by a range of linking mechanisms includ-
ing research collaboration, industrial inputs to curriculum development,
student placements, and exchange of scientific staff.
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A strong focus is placed on long-term relationship-building rather than
acquisition of specific expertise or technologies. The intention behind such
partnerships, according to a senior manager responsible for university links
in ICT2, is to have early access to the best ideas and people:
 
“So it’s early access to the best ideas and trusted access to the best ideas. And
so they know they have a good partner who’s not going to rip them off. And
that same thing applies, I think, to getting hold of the best talent, people. One
of the specific projects that I’m doing is developing strategic university rela-
tions program for ICT2 Labs. And the objectives of the program are to develop
a network of deep relationships with key institutions––building on that base
probably, to recruit the most innovative and entrepreneurial people from the
best universities . . .” (university relations manager, ICT2).
 
By becoming a trusted partner in the academic community, firms are not
only in a better position to gain access to the best researchers, but also have
an opportunity to influence the education and training of future employees:
 
“. . . by having the deep relationship with key universities, then you can spot
and encourage people to come to you with the right skill. Because you’ve got
this relationship with the lecturer, you can now influence what those PhDs do:
We would like you to be in [this area X] and why don’t you go and look at this
particular area of X. Come and see what we do, come and see if  you can
improve it . . .” (R&D director, Pharma2).
 
Furthermore, developing long-term stable relationships with their aca-
demic partners also provides firms with an established channel and trusted
information sources to recruit a core group of researchers with the neces-
sary competence profiles:
 
“The recruitment side is very important. They want to be able to get access to
students and to try and target and persuade the best one, the ones that fit their
profile . . .” (professor, academic partner of ICT2).
Hybrid Organizations as Overlapping Knowledge Networks. The hybrid
research organization is another mechanism used by the network firms to
create an overlapping social space where scientists from industry and
university can interact and work in close proximity. It seeks to establish an
organizational infrastructure for recruiting and developing a pool of human
resources with competence and careers straddling industry and the academia.
ICT2, for example, set up a basic research institute in mathematics in the
mid-1990s as part of the company’s basic research initiative to widen its
research base. The institute sits at the interface between ICT2 lab and its
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partner university, providing a forum for joint recruitment, collaborative
activities, and personnel exchanges. The core research staff  comprises a
mixed blend of ICT2 researchers, academic scientists jointly appointed by
the company and university, and postdoctoral and PhD students working
on projects jointly supervised by academic and industrial scientists. Like-
wise, ICT3 has also recently established a university-based laboratory sup-
ported by joint appointments, aiming at developing a novel area of expertise
outside the company’s core competence. The intention behind this, accord-
ing to the academic relations manager interviewed, is to create an extended
pool of human resources with “continuity of experience and knowledge”
that the company can draw upon when needed.
The hybrid organization creates a permeable boundary between firms and
universities. It seeks to integrate the business and science systems within a
single organization in order to facilitate knowledge exchange.
The “Linked Scientists” and Network Nodes in Knowledge Transfer. At the
core of the network firms’ strategies for developing closer ties with their
academic partners is the creation of a pool of human resources, the “linked
scientists,” who engage in the practices of both science and business, and
work on common projects in collaborative scientific teams. Such collabo-
rative teams constitute vital mechanisms for the capture and transfer of
knowledge across organizational boundaries. Zucker, Darby, and Torero
(2002) use the term “linked scientist” to refer to academic scientists
collaborate on joint research projects with a firm. Here, I use the term more
broadly to describe a growing category of scientists whose work and careers
straddle industry and the academia. These “linked scientists” play a vital role
in shaping the overlapping knowledge networks between firms and univer-
sities. Their hybrid career experiences and mobility between the two sectors
become key mechanisms for knowledge sharing and transfer.
There are three categories of researchers who perform the role of “linked
scientists” in bridging the interface between science and business. The first
concerns the “entrepreneurial” professors who have ongoing collaborative
links with firms but retain their full university positions. The second con-
cerns the “joint appointments” or postdocs who are formally affiliated to
the university but work on collaborative projects with firms. And the third
concerns the doctoral students who are selected and funded on the basis of
criteria negotiated between the firm and its academic partners, some of
whom may subsequently be employed by the firm. Together they constitute
the knowledge network nodes in firms university partnerships, and provide
the human resource links enabling firms to connect their internal R&D with the
external academic knowledge base.
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The “Entrepreneurial” Professors as Focal Links. The “entrepreneurial”
professors are the focal points of firms’ links to the universities. They are
academic scientists who participate in both the scientific and business
communities, and are active in building inter-institutional ties through
sponsored research, student placements, consulting, and company advisory
board membership. All the network firms have developed their university
partnerships through the personal contacts and deep engagement of such
entrepreneurial professors in the collaborative relationships. Pharma2, for
instance, has recently engaged in a 5-year large-scale consortium research
project with a university in Scotland. The engine behind the creation of the
project was a “star” bio-scientist who had developed strong personal links
with Pharma2 through consultancy activities and advisory board member-
ship. While maintaining his full university status, the professor has become
a vital source of intellectual capital for Pharma2 through joint research, and
his key role in creating and transferring early discovery results via direct
contacts with Pharma2 scientists. He also acts as a magnet for attracting
other top scientists to his team, providing a source of reliable researchers
for the collaborative project.
ICT2’s strategic partnership with a university in the west of England also
revolves around an entrepreneurial scientist who had been an industrial
researcher in computer science for 15 years before joining the academia. His
relationship with ICT2 dated back to his years in industry where he had
built a strong reputation in both the business and academic communities.
His arrival at the university gave a strong impetus to the partnership
through funding of research projects and drawing up a broad framework
agreement to facilitate personnel-based exchanges including student place-
ments, visiting staff  arrangements, and participation of firm scientists in
curriculum development and project supervision. Thus, this professor not
only represents a centre of expertise for ICT2, he is also the main conduit
through which ICT2 gains access to students and influences their training
early on.
Likewise, the relationship between ICT3 and a university based in
London builds on the work of a prominent academic in opto-electronics whose
long-standing relationship with the firm started in the 1970s when he was
completing his doctorate. ICT3 subsequently funded his appointment at the
university with a contractual obligation to work on areas of  interest to
the company, defined in broad terms. While maintaining his position as
a university employee, this professor’s work is governed by contractual
arrangements with ICT3. Through the long-standing relationship with this
professor, ICT3 has been able to develop multiple links with the university
in both research and educational programs.
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The Postdoctoral Researchers as “Joint” Human Capital. The postdoctoral
researchers are a growing category of “linked scientists” situated at the
interface between industry and the academia. These are usually young
scientists located half-way between training and scientific employment who are
employed for a fixed duration on industrial collaborative projects. For the
firms, these researchers constitute a pool of flexible scientific labour and a
repository of new knowledge that they can draw upon but without having
to commit themselves to a period of employment of more than 2 to 3 years.
For the universities, these funded positions enable them to offer temporary
employment to their new PhDs while they build up their research record
and wait for permanent positions in either the academia or industry. Some
of these researchers may eventually be recruited by the sponsored firms
which seek direct transfer of project experience into their R&D laboratories.
A professor engaged in a major collaborative project with a consortium of
pharmaceutical companies talked about how the companies are trying to
pick some of his “star” postdocs. Another senior academic saw the post-
doctoral positions as opportunities for some of his younger colleagues to
“get their faces known in the companies” and as vehicles for career moves
from the academia to industry.
The postdoctoral researchers represent a kind of joint human capital
shared between firms and universities within a temporary and dynamic
transitional scientific labour market characterized by mobility and flows of
people between the two sectors.
The Doctoral Students as a New Breed of “Hybrid” Scientists. Another cat-
egory of “linked scientists” is provided by the doctoral students whose com-
petence are jointly produced by universities and firms through some kind
of private–public collaborative education and training programs. All the
network firms use such programs to strengthen links with their academic
partners, and influence postgraduate training in order to develop a new
breed of hybrid scientists capable of operating in a “mode 2” problem-
solving context. ICT3, for example, has been a key participant of the engi-
neering doctoral program in telecommunications at one of  its partner
universities. This involves regular teaching inputs, joint supervision of projects
and advisory board memberships. The most important aspect of the sponsor-
ship, according to the professors interviewed, is not so much the funding
itself, but the supervision inputs from the industrial partners, and provision
of opportunities for the research students to “learn in context” through
direct engagement in solving industrial problems. This resembles a kind of
“informal apprenticeship” which allows industrial practice to penetrate
academic training, and facilities the reverse-flow of knowledge from industry
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to universities by shaping the skills and competence of the new generation
of scientists. Several of the professors pointed out how their industrial part-
ners use the relationships with them to get the students they need and to
“match” their competencies to the roles in the companies.
Evidence from the interviews suggests that firms tend to hire those who
have interned with them. The employment of these students further
strengthens the firms’ network ties with their academic partners.
Towards the Formation of “Extended Internal Labour Markets” 
(EILMs)
The network firms are devising new mechanisms to support skills and
knowledge sourcing. A main thrust of this has been the development of
human resource linkages and career structures to break down the cognitive
and institutional barriers between industry and university, and to incorpo-
rate academic scientists into the firms’ knowledge networks. As a result, a
growing number of scientists operate at the emerging overlapping space
between firms and universities, leading to the formation of  a common
scientific community spanning the two sectors.
For the firms, the extension of their knowledge networks into the academia
and the employment of  a pool of  “linked scientists” through affiliation
and sponsorship amounts to the formation of  what might be called
an “extended internal labour market” (EILM). The basic idea behind this
concept builds on that of a firm’s internal labour market, and how it may be
extended beyond the boundary of the firm following established recruitment
channels. Manwaring (1984) first used the term “EILM” to describe how
firms recruit through their existing employees and seek to extend their inter-
nal labour markets through their social networks in the local community
(Manwaring 1984). Here, I apply the concept in a broader sense to stress
the active role of firms in developing social networks for knowledge and
skills resourcing, and also to highlight the critical role of careers and mo-
bility of people in the transmission and sharing of knowledge across organi-
zational boundaries. The arrangements set up between the firms and
universities provide stable frameworks for supporting cooperation and
knowledge production in flexible project networks. More specifically, they
perform four important functions associated with EILMs. First, they provide
effective channels for blending industrial problem-solving with academic
modes of  knowledge production, and thus facilitating the coproduction
of  new knowledge that has commercial applications. Second, they serve
as informal apprenticeship systems for shaping joint human capital. They
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enable firms to shape unique human resources required for connecting their
internal knowledge with new knowledge generated through collaborative
projects. They also constitute established avenues for transmitting reliable
information about the competence of potential recruits. Third, they serve as
a selection and screening mechanism as the entrepreneurial professors filter
those whom they choose as postdoctoral collaborators. And fourth, more
critically, they enable firms to retain stable jobs and scientific careers for
members of the extended core based at their partner universities. As firms
seek to break away from the constraints of their internal R&D system and
firm-based careers, the relationship with universities provides an effective
solution enabling them to gain access to the top researchers whom “they
would never be able to get unless they were to offer them the security of
lifetime jobs,” to put it in the words of a professor collaborating with ICT2.
Thus, EILMs provide career structures and incentives to ensure that aca-
demic scientists are willing to engage in short-duration industrial projects
while maintaining their positions at universities and remaining integrated
into the academic scientific community. In this context, one can argue that
the large innovative firms have not abandoned their internal labour markets
but have sought to transform the way they operate by making use of the
career systems provided by universities.
However, for the individual academic scientists incorporated into the
firms’ EILMs, their simultaneous engagement in the science and business
systems can cause a great deal of role pressure and tension. Indeed, evid-
ence based on this study and elsewhere (Turpin and Deville 1995; Cohen,
Duberley, and McAuley 1999) suggests that academic scientists increasingly
experience many of the traditional dilemmas encountered by their industrial
colleagues. To start with, balancing the fundamental differences between
the academic norm of free communication and the industrial requirements
of confidentiality is problematic. Many of the academic scientists inter-
viewed regard confidentiality as a thorny issue in their collaborative
relationships with firms as this may deprive them of the opportunities to
gain recognition in the scientific community. This can be a serious problem
for younger scientists, especially those employed on short-term projects,
who are often dependent on the research output of these projects to secure
future long-term employment in the academia. A study by Slaughter,
Campbell, Holleman, and Morgan (2002) also suggests that “secrecy” and
delayed publications can potentially jeopardize the careers of  doctoral
students engaged in industrial projects. Moreover, for many of the “linked
scientists,” striking the right balance between academic scientific goals and
industrial objectives in their research appears to be a sensitive issue. The
following comment by an “entrepreneurial” professor expresses this sentiment:
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“. . . if  you sort of  do their [the companies’] problems that does not give you
credit in your own environment, then you are solving the wrong kind of problems”.
The blurring of boundaries between university and industry, and the
hybridization of occupational roles and careers within firms’ EILMs mean
that the same individual scientist can be a “private” industrial researcher as
well as “public” academic scientist. While the comingling of  ideas and
perspectives of the two different systems can be a source of creativity and
new knowledge, balancing the divergent, and at times conflicting, demands
of these two different systems remains an immensely challenging task for
the scientists involved.
Conclusion
By comparing market-pull and network firms, this paper has explored the
changing work roles and careers of R&D scientists as the latter types of firms
increasingly extend their knowledge networks into the academic scientific
community to compensate for the weaknesses of internal R&D. It argues
that the increased interchange between industry and the academia is
leading to the emergence of a hybrid scientific community with a growing
number of scientists in knowledge networks straddling the two sectors. This
community consists of  a blend of  industrial researchers and academic
scientists working on common projects in collaborative scientific teams. The
interchange and mobility of scientific personnel between the two communi-
ties constitutes a key mechanism in supporting the collaborative knowledge
networks between industry and university. The paper draws attention to
the notion of  an “extended internal labour market” as one particular
form of institutional mechanism underpinning the network model of R&D
organization.
While firms have used their EILMs to support the hybrid community to
tap into the open knowledge networks of universities, the resulting incorpo-
ration of academic scientists as key actors in firms’ innovation process has
caused worries about the basic knowledge creation role of universities.
Some authors have also raised concerns about the difficulties in containing
the conflicts that are likely to arise from the lack of congruence between the
goals and careers sought by members from the private proprietary and
public open scientific communities (David, Foray, and Steinmueller 1999).
For the individual scientists, the increased overlap between industry and the
academia creates opportunities for developing new competences, and
pursuing alternative career options outside their own research communities.
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However, the tension inherent in the nature of the relationship between the
science and business systems, and the “temporary” state of many of the col-
laborative projects mean that the career paths for those engaged in hybrid
work roles could be fragile and uncertain. Among the possible losers in this
process are the “trapped” postdoctorates employed on “soft” money, and
graduate students used as cheap scientific labourer in industry-university
exchanges (Stephan and Levin 1997; Slaughter et al. 2002).
This paper has sought to contribute to our understanding of how the
evolution of industrial R&D shapes the work roles and careers of scientific
personnel by contrasting their nature in two types of firms. Although the
in-depth case studies shed light on key aspects of new models of careers and
employment underpinning knowledge production in network organizations,
the nature of the sample calls for some qualifications. First, the sample is
small––a constraint on all case studies. Second, those interviewed might be
considered “insiders”, who have benefited from the changes and so see the
problems in a positive light. This might exaggerate the stability of the EILM
arrangements and their ability to appeal to academic scientists. Future
research is needed to gain a deeper understanding of the operation of
EILMs from the perspectives of a broader cross-section of scientists. The
role of the linked scientists and their positions in firms’ EILMs deserve
particular attention in future investigation.
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